...
首页> 外文期刊>Archiv der Pharmazie >Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives.
【24h】

Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives.

机译:某些功能不同的螺环丙基衍生物对人类免疫缺陷病毒类型(HIV-1)复制的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Inhibition of HIV-1 replication by differently substituted spirocyclopropyl compounds has been evaluated. Compound 21 showed a moderate activity (EC50 ranging from 2.3 to 5.8 micrograms/ml) against different HIV-1 strains (IIIB, RF, NDK, and an AZT-resistant strain) in different cell lines (MT-4 and C-8166 cells), while it was cytotoxic at 77.7 micrograms/ml, resulting in a selectivity index of 34. This compound was inactive against HIV-2 (ROD) and SIV (MAC251). From "time-of-addition" experiments compound 21, like AZT, appeared to inhibit HIV-1 at the reverse transcriptase step.
机译:已经评估了不同取代的螺环丙基化合物对HIV-1复制的抑制作用。化合物21在不同的细胞系(MT-4和C-8166细胞)中对不同的HIV-1株(IIIB,RF,NDK和AZT耐药株)表现出中等活性(EC50在2.3至5.8微克/毫升之间) ),但在77.7微克/毫升时具有细胞毒性,因此选择性指数为34。该化合物对HIV-2(ROD)和SIV(MAC251)无活性。从“添加时间”实验中,化合物21(如AZT)似乎在逆转录酶步骤中抑制HIV-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号